The open index of psychedelic research

Open datasets, papers, preregistrations, and trials from across psychedelic science.

11,281 records6 sources
Showing 1,681–1,704 of 11,281
PreprintPsychedelics

Egostasis: A First-Principles Account of the Neurocomputational Basis of Suffering

Cooke J

Europe PMC2026
PreprintPsilocybin

The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum Disorder

Marini S, De Berardis D

Europe PMC2026
ArticleKetamine

Pharmacological augmentation in treatment-resistant depression: a neurobiologically informed, practical decision guide for treatment choice with lithium, quetiapine, or esketamine.

Eckert D, Kasper S

Europe PMC2026
ArticleKetamine

Impact of esketamine-based opioid-free anesthesia on quality of recovery after laparoscopic hysterectomy: a randomized controlled trial using the QoR-40 questionnaire.

Chen Y, Qin P, Tian E +3

Europe PMC2026
ArticleLSD

Evaluating the evidence for repressed memory recovery in psychedelic contexts.

Griesfeller AF, Kooman L, Kloft-Heller L +3

Europe PMC2026
ArticlePsychedelics

Secular Mysticism: Entanglements of Science and Religion in Psychedelic Medicine.

Seale-Feldman A

Europe PMC2026
ArticlePsychedelics

Polysubstance use disorders among US adults.

Han B, Volkow ND, Jones CM +7

Europe PMC2026
ArticlePsilocybin

The Harmonious Dance: A Narrative Review on Psychedelics and Music in Therapeutic Settings.

Wang H, Li X, Yu F +1

Europe PMC2026
ArticlePsilocybin

Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants.

Arikci D, Borgulya J, Straumann I +8

Europe PMC2026
ArticlePsilocybin

Psilocybin-assisted psychotherapy for psycho-existential distress in advanced cancer: a narrative review.

Magnani L, Ghirotto L, Fesce F +4

Europe PMC2026
ArticlePsychedelics

Spiritual transformation in psychedelic-assisted palliative care: Implications for existential and postmodern counseling practice.

Kurniawan SJ, Wiyono BD, Naqiyah N +1

Europe PMC2026
PreprintPsilocybin

A 128-Channel Wireless Wearable Myolink (W2 Myolink): Functional Characteristics and Multidisciplinary Experiments

Zajaczkowski M, Koutsoftidis S, Sheeraz M +10

Europe PMC2026
ArticlePsychedelics

A critical review of brain entropy as a biomarker of the psychedelic state.

Moses B, Doss MK, Tagliazucchi E

Europe PMC2026
ArticlePsilocybin

Fusing Specialized Surveys of Rare Populations to Larger Surveys for Generalized Inference: Cross-Sectional Survey Study.

Rockhill KM, Bemis EA, Schow N +5

Europe PMC2026
ArticleKetamine

Esketamine for Postoperative Multimodal Analgesia in Laparoscopic Surgery: A Systematic Review and Meta-Analysis.

Li J, Wang X

Europe PMC2026
ProjectIbogaine

Cardiovascular safety of ibogaine in adults: a systematic review of the clinical evidence, 1990–2026

OSF2026
ArticleKetamine

Concurrent SSRI, SNRI, or Other Antidepressant Use Not Associated With Differential Outcomes in Ketamine or Esketamine Treatment.

Curran E, Hardy M, Katz R +2

Europe PMC2026
PreregistrationPsilocybin

Psilocybin and Irritable Bowel Syndrome: A Scoping Review of the Existing Evidence

OSF2026
PreprintMDMA

Occurrence and short-term variability of psychoactive substances in wastewater from a mixed urban catchment in central Chile

Calzadilla W, Montenegro K, Yar A +2

Europe PMC2026
ArticlePsychedelics

Novel Indoline Derivatives Serotonergic Psychedelic Agents as 5‑HT2A Agonists for Treating Psychosis, Mental Illness and CNS Disorders.

Sabnis RW, Sabnis AR

Europe PMC2026
ArticlePsychedelics

Trump's psychedelic executive order: president expands access to psychoactive drugs.

Reddick R

Europe PMC2026
TrialKetamine

A 2×2 Factorial Randomized Controlled Trial for ERCP

ClinicalTrials.gov2026
ArticleKetamine

Repeated intranasal esketamine augmentation in treatment-resistant obsessive-compulsive disorder with comorbid major depressive disorder: a prospective case series.

López-Rodríguez S, Segalàs C, Real E +4

Europe PMC2026
ArticleMDMA

High temporal resolution monitoring of illicit drug consumption across England via wastewater analysis.

Rapp-Wright H, Ng KT, Grant D +12

Europe PMC2026